BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8648108)

  • 1. Murine NK cell allospecificity-1 is defined by inhibitory ligands.
    Zheng WP; Kiura K; Milisauskas VK; DeNardin E; Nakamura I
    J Immunol; 1996 Jun; 156(12):4651-5. PubMed ID: 8648108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ability of H-2Dd molecule to affect natural resistance to hemopoietic allografts is an intrinsic property shared by Ddm1 but not Ld.
    Milisauskas VK; Nakamura I
    Eur J Immunol; 1994 Feb; 24(2):336-42. PubMed ID: 8299682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
    Karlhofer FM; Ribaudo RK; Yokoyama WM
    Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allospecificities of B6D2F1 hybrid NK cell subsets defined by Ly-49A expression.
    Basiri H; Kiura K; DeNardin EG; Nakamura I
    J Immunol; 1995 Sep; 155(6):2822-32. PubMed ID: 7673698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of F1 anti-parental resistance in H-2b/d F1 hybrids devoid of beta2-microglobulin.
    Höglund P; Olsson-Alheim MY; Johansson M; Kärre K; Sentman CL
    Eur J Immunol; 1997 Jan; 27(1):342-5. PubMed ID: 9022038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
    Rembecki RM; Bennett M; Kumar V; Potter TA
    J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
    Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
    J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
    Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
    J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor.
    Lian RH; Freeman JD; Mager DL; Takei F
    J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulatory functions of Ly-49A, Ly-49D and Ly-49G2 on NK cells in the recognition and rejection of the alloantigen in vivo.
    Shimizu I; Tomita Y; Iwai T; Zhang QW; Matsuzaki G; Nomoto K; Yasui H
    Transpl Int; 2005 Sep; 18(9):1090-9. PubMed ID: 16104890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MHC class I molecule H-2Dp inhibits murine NK cells via the inhibitory receptor Ly49A.
    Olsson-Alheim MY; Sundbäck J; Kärre K; Sentman CL
    J Immunol; 1999 Jun; 162(12):7010-4. PubMed ID: 10358142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alpha2 domain of H-2Dd restricts the allelic specificity of the murine NK cell inhibitory receptor Ly-49A.
    Sundbäck J; Nakamura MC; Waldenström M; Niemi EC; Seaman WE; Ryan JC; Kärre K
    J Immunol; 1998 Jun; 160(12):5971-8. PubMed ID: 9637511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
    Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
    J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of class I MHC by NK receptor Ly-49C: identification of critical residues.
    Lian RH; Li Y; Kubota S; Mager DL; Takei F
    J Immunol; 1999 Jun; 162(12):7271-6. PubMed ID: 10358175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered donor and recipient Ly49+ NK cell subsets in allogeneic H-2d --> H-2b and H-2b --> H-2d bone marrow chimeras.
    Korten S; Wilk E; Gessner JE; Meyer D; Schmidt RE
    J Immunol; 1999 Dec; 163(11):5896-905. PubMed ID: 10570275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells.
    George TC; Mason LH; Ortaldo JR; Kumar V; Bennett M
    J Immunol; 1999 Feb; 162(4):2035-43. PubMed ID: 9973475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning of minimally divergent allelic forms of the natural killer (NK) receptor Ly-49C, differentially controlled by host genes in the MHC and NK gene complexes.
    Sundbäck J; Kärre K; Sentman CL
    J Immunol; 1996 Nov; 157(9):3936-42. PubMed ID: 8892625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance and alloreactivity of the Ly49D subset of murine NK cells.
    George TC; Ortaldo JR; Lemieux S; Kumar V; Bennett M
    J Immunol; 1999 Aug; 163(4):1859-67. PubMed ID: 10438920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of interaction between Ly49 inhibitory receptors and cognate MHC I molecules in IL2-induced development of NK cells in murine bone marrow cell cultures.
    Das A; Saxena RK
    Immunol Lett; 2004 Jul; 94(3):209-14. PubMed ID: 15275968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement.
    Kim S; Yokoyama WM
    Cell Immunol; 1998 Feb; 183(2):106-12. PubMed ID: 9606994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.